Document Type
Article
Publication Date
1-23-2024
Identifier
DOI: 10.20411/pai.v10i1.734; PMCID: PMC11792536
Abstract
BACKGROUND: Antibody-dependent cell-mediated cytotoxic (ADCC) response mediated by natural killer (NK) cells correlates with decreased infection risk in studies involving simian immunodeficiency virus (SIV)/simian-human immunodeficiency virus (SHIV), and human immunodeficiency virus (HIV) vaccine candidates. Currently, the heterogeneities of the functional subset of rhesus macaque natural killer (RMNK) cells are under-characterized.
METHOD: We engaged the RMNK cells with ADCC-mediating anti-HIV-1 monoclonal antibodies (ADCCAbs) or anti-CD16 antibodies and used CD107a expression as the surrogate marker for RMNK cells actively involved in ADCC. CD107a+ and CD107a- populations were analyzed individually using single-cell RNA sequencing.
RESULTS: Subsets of CD107a+ RMNK cells produced more chemokines than the others, suggesting that these cells not only eliminate infected cells but also provide immunoregulatory signals and potentially curb HIV-1 replication. Crosslinking of Fc gamma receptor IIIa via anti-CD16 antibodies resulted in a significantly higher percentage of degranulating cells than via ADCCAbs. However, the magnitude of degranulation and chemokine production was reduced by 6- to 30-fold.
CONCLUSION: The quality and quantity of receptor engagement are important determinants of achieving an optimal level of the RMNK response.
Journal Title
Pathog Immun
Volume
10
Issue
1
First Page
49
Last Page
79
PubMed ID
39911143
Keywords
Antibody-Dependent Cell Cytotoxicity; Chemokine; NK cells; Rhesus Macaque; Single-Cell Gene Expression Analysis
Recommended Citation
Nohara J, Evangelous T, Berry M, et al. Increased Chemokine Production is a Hallmark of Rhesus Macaque Natural Killer Cells Mediating Robust Anti-HIV Envelope-Specific Antibody-Dependent Cell-Mediated Cytotoxicity. Pathog Immun. 2025;10(1):49-79. Published 2025 Jan 23. doi:10.20411/pai.v10i1.734
Comments
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
Publisher's Link: https://doi.org/10.20411/pai.v10i1.734